skip to Main Content

“ACT’s innovative structure and ability to accelerate the delivery of practice informing trials in conjunction with the UK haematology-oncology community will be of real benefit to blood cancer patients for whom new and more effective therapies are so urgently needed”

Prof Graham Jackson
Consultant Haematologist at Newcastle Hospitals NHS Foundation Trust